Chonju, Korea, Republic of Clinical Trials

A listing of Chonju, Korea, Republic of clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 56 clinical trials
Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial

The purpose of this study is to assess the usefulness of laparoscopic surgery for gastric cancer in comparison with open gastrectomy.

laparoscopy
gastric adenocarcinoma
adenocarcinoma
gastrectomy
Keimyung University College of Medicine
 (81.2 away) Contact site
  • 14 views
  • 07 Nov, 2020
  • +9 other locations
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-845.

  • 0 views
  • 27 Jan, 2021
  • 1 location
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer

The primary goal of this phase II trial is to evaluate the response rate of combination chemotherapy with S-1 and Irinotecan in patients with advanced gastric cancer as a first-line therapy.

adjuvant chemotherapy
metastasis
x-rays
liver metastasis
immunostimulants
Chonnam National University Hwasun Hospital
 (53.4 away) Contact site
  • 13 views
  • 07 Nov, 2020
  • +5 other locations
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

This is a phase 3, multicenter, randomized, double-blind, placebo-controlled trial designed to compare the efficacy and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed DLBCL

MorphoSys Research Site
 (111.5 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +267 other locations
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). The first cohort will assess the objective response rate (ORR) of tipifarnib in subjects with HNSCC with HRAS mutations. The second study cohort, SEQ-HN, is an observational sub-study and includes 2 …

measurable disease
caries
neck cancer
HRAS
cancer
The Catholic University of Korea St. Vincent's Hospital
 (99.3 away) Contact site
  • 3 views
  • 08 Mar, 2021
  • +137 other locations
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe exacerbations in COPD participants given as an add on to their optimized maintenance COPD therapy. The maximum duration of participant participation is approximately 57 weeks, consisting of 2 …

eosinophil count
albuterol
copd exacerbation
cigarette smoke
fluticasone
GSK Investigational Site
 (81.2 away) Contact site
  • 379 views
  • 15 Apr, 2021
  • +204 other locations
Tezepelumab COPD Exacerbation Study

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

bronchodilator
ct scan
copd exacerbation
severe chronic obstructive pulmonary disease
Research Site
 (81.2 away) Contact site
  • 130 views
  • 16 May, 2021
  • +106 other locations
GEN3013 Trial in Patients With Relapsed Progressive or Refractory B-Cell Lymphoma

The trial is an open-label, multi-center safety trial of epcoritamab GEN3013 (DuoBody-CD3xCD20). The trial consists of two parts: a dose escalation part phase 1, first-in-human (FIH) and an expansion part phase 2a.

monoclonal antibodies
stem cell transplantation
lymphoma
b-cell lymphoma
large b-cell lymphoma
Keimyung University Dongsan Medical Center
 (81.2 away) Contact site
  • 316 views
  • 24 Feb, 2021
  • +98 other locations
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

In this study, adults with newly-diagnosed Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) will receive first-line therapy of ponatinib or imatinib. The main aim of this study is to compare the number of participants on each treatment that show no signs of disease. Participants will take tablets of either ponatinib …

ponatinib
remission
minimal residual disease
imatinib
vincristine
Kyungpook National University Hospital
 (81.2 away) Contact site
  • 72 views
  • 16 May, 2021
  • +122 other locations
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive HER2-Negative Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

The purpose of this study is to evaluate the efficacy of zolbetuximab plus capecitabine and oxaliplatin (CAPOX) compared with placebo plus CAPOX (as first-line treatment) as measured by Progression Free Survival (PFS). This study will also evaluate efficacy, safety and tolerability of zolbetuximab, as well as its effects on quality …

Site KR82008
 (53.1 away) Contact site
  • 224 views
  • 16 Jun, 2021
  • +206 other locations